Home/Filings/4/0001567619-21-011972
4//SEC Filing

Stilwell McDavid 4

Accession 0001567619-21-011972

CIK 0001512762other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 4:35 PM ET

Size

5.5 KB

Accession

0001567619-21-011972

Insider Transaction Report

Form 4
Period: 2021-06-09
Stilwell McDavid
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2021-06-09$13.42/sh+3,700$49,66835,118 total
Footnotes (3)
  • [F1]The transaction was executed in multiple trades in prices ranging from $13.415 to $13.4294, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Includes 30,000 restricted stock units.
  • [F3]Includes 1,418 shares acquired on May 14, 2021, pursuant to Issuer's employee stock purchase plan.

Documents

1 file

Issuer

Coherus BioSciences, Inc.

CIK 0001512762

Entity typeother

Related Parties

1
  • filerCIK 0001851389

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:35 PM ET
Size
5.5 KB